Balla, S. R., Cyr, D., Lokhnygina, Y., Becker, R., Berkowitz, S., Breithardt, G., … Patel, M. (2014). OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL. In Journal of the American College of Cardiology (Vol. 63, pp. A371–A371). Elsevier BV. https://doi.org/10.1016/s0735-1097(14)60371-5

Balla, Somasekhara R., Derek Cyr, Yuliya Lokhnygina, Richard Becker, Scott Berkowitz, Guenter Breithardt, Robert Califf, et al. “OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL.” In Journal of the American College of Cardiology, 63:A371–A371. Elsevier BV, 2014. https://doi.org/10.1016/s0735-1097(14)60371-5.

Balla SR, Cyr D, Lokhnygina Y, Becker R, Berkowitz S, Breithardt G, et al. OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL. In: Journal of the American College of Cardiology. Elsevier BV; 2014. p. A371–A371.

Balla, Somasekhara R., et al. “OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL.” Journal of the American College of Cardiology, vol. 63, no. 12, Elsevier BV, 2014, pp. A371–A371. Crossref, doi:10.1016/s0735-1097(14)60371-5.

Balla SR, Cyr D, Lokhnygina Y, Becker R, Berkowitz S, Breithardt G, Califf R, Fox K, Hacke W, Halperin J, Hankey G, Mahaffey K, Nessel C, Piccini J, Singer D, Patel M. OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL. Journal of the American College of Cardiology. Elsevier BV; 2014. p. A371–A371.